Biotechnology
- U.S. News
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. …
Read More » - U.S. News
Eli Lilly’s Zepbound and Mounjaro are no longer in shortage. Here’s where their sales still disappointed
Eli Lilly’s blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as…
Read More » - U.S. News
Novo Nordisk’s Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Packages containing syringes of the medications Wegovy, Ozempic and Mounjaro at a shop in Mitte, Germany, July 11, 2024. Picture…
Read More » - U.S. News
CDC says 90 people affected in E. coli outbreak linked to McDonald’s Quarter Pounders
A Quarter Pounder with cheese, fries and a drink arranged at a McDonald’s restaurant in El Sobrante, California, on Oct.…
Read More » - U.S. News
Biogen tops estimates, raises profit guidance as Alzheimer’s drug Leqembi gains traction
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado…
Read More » - U.S. News
Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. Mike Blake | Reuters Eli Lilly on…
Read More » - News
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
Kena Betancur | Corbis News | Getty Images Pfizer on Tuesday reported third-quarter revenue and adjusted profit that blew past…
Read More » - U.S. News
CDC says 75 people affected in E. coli outbreak linked to McDonald’s Quarter Pounders
A deadly E. coli outbreak linked to McDonald‘s Quarter Pounders has led to 75 cases in 13 states, the Centers…
Read More » - U.S. News
Novo Nordisk’s diabetes drug Ozempic may reduce the risk of Alzheimer’s disease, study says
Steve Christo – Corbis | Corbis News | Getty Images Novo Nordisk‘s blockbuster diabetes drug Ozempic may reduce the risk…
Read More » - U.S. News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Novo Nordisk on Tuesday asked the Food and Drug Administration to prevent compounding pharmacies from making unapproved and often cheaper…
Read More »
